Patient and pediatric caregiver experiences and expectations about opioid risk education and counselling

Tanvee Thakur, BPharm, MS; Betty Chewning, PhD

doi:10.5055/jom.2020.0573

Authors

Tanvee Thakur, BPharm, MS
Betty Chewning, PhD

DOI:

https://doi.org/10.5055/jom.2020.0573

Keywords:

patient expectations, opioid, risk, safety, perceptions, counseling, education, pharmacist

Abstract

Objective: This pilot study seeks to explore patient and caregiver experiences, perceptions, and expectations about opioid risk counselling.

Design: Semistructured interviews were conducted in Madison, WI. Inductive content analysis was used for analysis.

Participants: Adult patients and pediatric caregivers for patients prescribed opioids in the last 30 days.

Outcome measure: Patient’s experiences, perceptions, and expectations about opioid risk and safety counselling.

Results: Two out of 16 patients were reported being counseled about risks, and only one patient was told about medication being an opioid. Respondents expressed their desire to learn about dependency and overdose risks and the fact that the medication is an opioid. While patients wanted to be educated by all healthcare providers, pharmacists were deemed most important for opioid risk counseling.

Conclusion: This unique study points out the need for more research, training, and resources for aligning opioid risk counselling and education with patient expectations as a patient centered effort.

Author Biographies

Tanvee Thakur, BPharm, MS

PhD Student, Social and Administrative Sciences in Pharmacy Division, University of Wisconsin-Madison School of Pharmacy, Madison, Wisconsin

Betty Chewning, PhD

Professor, Social and Administrative Sciences in Pharmacy Division, University of Wisconsin-Madison School of Pharmacy, Madison, Wisconsin

References

Center for Disease Control and Prevention: Opioid Overdose--Understanding the Epidemic. Atlanta, GA: Center for Disease Control and Prevention, 2018. Available at https://www.cdc.gov/drugoverdose/epidemic/index.html. Accessed September 13, 2019.

Compton WM, Jones CM, Stein JB, et al.: Promising roles for pharmacists in addressing the U.S. opioid crisis. Res Social Adm Pharm. 2017; 15(8): 910-916.

Centers for Disease Control and Prevention: Opioid Overdose--Communicating with Patients. Atlanta, GA: Centers for Disease Control and Prevention, 2018. https://www.cdc.gov/drugoverdose/training/communicating/index.html. Accessed September 13, 2019.

McCarthy DM, Cameron KA, Courtney DM, et al.: Communication about opioid versus nonopioid analgesics in the emergency department. J Opioid Manag. 2015; 11: 229-236.

McCarthy DM, Engel KG, Cameron KA: Conversations about analgesics in the emergency department: A qualitative study. Patient Educ Couns. 2016; 99: 1130-1137.

McCarthy DM, Cameron KA, King JP, et al.: Patient recall of health care provider counseling for opioid-acetaminophen prescriptions. Pain Med. 2014; 15: 1750-1756.

Mueller SR, Koester S, Glanz JM, et al.: Attitudes toward naloxone prescribing in clinical settings: A qualitative study of patients prescribed high dose opioids for chronic non-cancer pain. J Gen Intern Med. 2017; 32: 277-283.

Smith RJ, Rhodes K, Paciotti B, et al.: Patient perspectives of acute pain management in the era of the opioid epidemic. Ann Emerg Med. 2015; 66: 246-252.e241.

Lafferty L, Hunter TS, Marsh WA. Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse. J Psychoactive Drugs. 2006; 38: 229-232.

Peckham AM, Niculete ME, Steinberg H, et al.: A survey of prescribers’ attitudes, knowledge, comfort, and fear of consequences related to an opioid overdose education and naloxone distribution program. J Public Health Manag Pract. 2018; 24: 310-317.

Matthias MS, Krebs EE, Collins LA, et al.: “I’m not abusing or anything”: Patient-physician communication about opioid treatment in chronic pain. Patient Educ Couns. 2013; 93: 197-202.

Saunders B, Sim J, Kingstone T, et al.: Saturation in qualitative research: Exploring its conceptualization and operationalization. Qual Quant. 2018; 52: 1893-1907.

Kallio H, Pietila AM, Johnson M, et al.: Systematic methodological review: Developing a framework for a qualitative semistructured interview guide. J Adv Nurs. 2016; 72: 2954-2965.

Elo S, Kyngas H: The qualitative content analysis process. J Adv Nurs. 2008; 62: 107-115.

Houghton C, Murphy K, Meehan B, et al.: From screening to synthesis: Using nvivo to enhance transparency in qualitative evidence synthesis. J Clin Nurs. 2017; 26: 873-881.

Connelly LM, Peltzer JN: Underdeveloped themes in qualitative research: Relationship with interviews and analysis. Clin Nurse Spec. 2016; 30: 52-57.

Matthias MS, Krebs EE, Bergman AA, et al.: Communicating about opioids for chronic pain: A qualitative study of patient attributions and the influence of the patient-physician relationship. Eur J Pain. 2014; 18: 835-843.

Constand MK, MacDermid JC, Dal Bello-Haas V, et al.: Scoping review of patient-centered care approaches in healthcare. BMC Health Serv Res. 2014; 14: 271.

Hagemeier NE, Murawski MM, Lopez NC, et al.: Theoretical exploration of Tennessee community pharmacists’ perceptions regarding opioid pain reliever abuse communication. Res Social Adm Pharm. 2014; 10: 562-575.

Hughes HK, Korthuis PT, Saha S, et al.: A mixed methods study of patient-provider communication about opioid analgesics. Patient Educ Couns. 2015; 98: 453-461.

Traynor K: REMS standardization moves forward. Am J Health Syst Pharm. 2017; 74: 1928.

Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS): Food and Drug Administration, 2018. Available at https://www.fda.gov/drugs/information-drug-class/opioid-analgesic-risk-evaluation-andmitigation-strategy-rems. Accessed September 13, 2019.